Marianna B. Ruzinova, Ph.D. - Publications

Affiliations: 
2004 Weill Cornell Medical College, New York, NY, United States 
Area:
Cell Biology, Genetics, Oncology, Molecular Biology

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Li Q, Chen Y, Zhang D, Grossman J, Li L, Khurana N, Jiang H, Grierson P, Herndon J, DeNardo DG, Challen GA, Liu J, Ruzinova MB, Fields RC, Lim KH. IRAK4 mediates colitis-induced tumorigenesis and chemoresistance in colon cancer. Jci Insight. PMID 31527315 DOI: 10.1172/Jci.Insight.130867  0.365
2018 Zhang D, Li L, Jiang H, Li Q, Wang-Gillam A, Yu J, Head R, Liu J, Ruzinova MB, Lim KH. Tumor-stroma IL-1β-IRAK4 feedforward circuitry drives tumor fibrosis, chemoresistance, and poor prognosis in pancreatic cancer. Cancer Research. PMID 29363544 DOI: 10.1158/0008-5472.Can-17-1366  0.402
2018 Zhang D, Li L, Jiang H, Wang-Gillam A, Yu J, Head R, Liu J, Ruzinova MB, Lim K. Abstract 995: Tumor-stroma IL-1β-IRAK4 feedforward circuitry drives tumor fibrosis, chemo-resistance and is associated with poor prognosis in pancreatic cancer Tumor Biology. DOI: 10.1158/1538-7445.Am2018-995  0.398
2016 Brauer DG, Strand MS, Sanford DE, Kushnir VM, Lim KH, Mullady DK, Tan BR, Wang-Gillam A, Morton AE, Ruzinova MB, Parikh PJ, Narra VR, Fowler KJ, Doyle MB, Chapman WC, et al. Utility of a multidisciplinary tumor board in the management of pancreatic and upper gastrointestinal diseases: an observational study. Hpb : the Official Journal of the International Hepato Pancreato Biliary Association. PMID 27916436 DOI: 10.1016/J.Hpb.2016.11.002  0.361
2016 Watson R, Liu TC, Ruzinova MB. High Frequency of KRAS Mutation in Early Onset Colorectal Adenocarcinoma: Implications for Pathogenesis. Human Pathology. PMID 27346571 DOI: 10.1016/J.Humpath.2016.06.010  0.345
2016 Brauer DG, Strand MS, Sanford DE, Doyle MM, Murad F, Mullady D, Kushnir VM, Ruzinova M, Olsen JR, Parikh PJ, Lim K, Tan BR, Edmundowicz SA, Wang-Gillam A, Hawkins WG, et al. Utility of a multidisciplinary tumor board in the management of pancreatic diseases. Journal of Clinical Oncology. 34: 319-319. DOI: 10.1200/Jco.2016.34.4_Suppl.319  0.304
2016 Zhang D, Li L, Jiang H, Yu J, Knolhoff B, Head R, Lockhart AC, DeNardo DG, Wang-Gillam A, Ruzinova MB, Lim K. Abstract 181: Constitutive IRAK1/4 kinase activation contributes to NF-kB activity and chemoresistance in pancreatic cancer Cancer Research. 76: 181-181. DOI: 10.1158/1538-7445.Am2016-181  0.345
2010 Ruzinova MB, Caron T, Rodig SJ. Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation. The American Journal of Surgical Pathology. 34: 882-91. PMID 20442643 DOI: 10.1097/Pas.0B013E3181Db83Af  0.33
2006 Benezra R, Henke E, Ciarrocchi A, Ruzinova M, Solit D, Rosen N, Nolan D, Mittal V, de Candia P. Induction of complete regressions of oncogene-induced breast tumors in mice. Cold Spring Harbor Symposia On Quantitative Biology. 70: 375-81. PMID 16869774 DOI: 10.1101/Sqb.2005.70.006  0.567
2003 Ruzinova MB, Schoer RA, Gerald W, Egan JE, Pandolfi PP, Rafii S, Manova K, Mittal V, Benezra R. Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell. 4: 277-89. PMID 14585355 DOI: 10.1016/S1535-6108(03)00240-X  0.579
2003 Ruzinova MB, Benezra R. Id proteins in development, cell cycle and cancer. Trends in Cell Biology. 13: 410-8. PMID 12888293 DOI: 10.1016/S0962-8924(03)00147-8  0.517
2003 Benezra R, de Candia P, Li H, Romero E, Lyden D, Rafii S, Ruzinova M. A genetic approach to understanding tumor angiogenesis. Cold Spring Harbor Symposia On Quantitative Biology. 67: 249-54. PMID 12858547 DOI: 10.1101/Sqb.2002.67.249  0.546
Show low-probability matches.